122 related articles for article (PubMed ID: 37823514)
21. SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma.
Singh P; Srinivasan R; Wig JD
Pancreas; 2012 May; 41(4):541-6. PubMed ID: 22504380
[TBL] [Abstract][Full Text] [Related]
22. Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation.
Herman JM; Jabbour SK; Lin SH; Deek MP; Hsu CC; Fishman EK; Kim S; Cameron JL; Chekmareva M; Laheru DA; Narang AK; Pawlik TM; Hruban RH; Wolfgang CL; Iacobuzio-Donahue CA
Pancreas; 2018 Feb; 47(2):208-212. PubMed ID: 29329157
[TBL] [Abstract][Full Text] [Related]
23. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Hu Y; Chen Y
Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer.
Pokataev I; Kudaibergenova A; Artemyeva A; Popova A; Rumyantsev A; Podluzhny D; Kudashkin N; Fedyanin M; Tryakin A; Tjulandin S
J Gastrointest Cancer; 2019 Sep; 50(3):478-484. PubMed ID: 29675723
[TBL] [Abstract][Full Text] [Related]
26. Using next-generation sequencing to determine potential molecularly guided therapy options for patients with resectable pancreatic adenocarcinoma.
Wright GP; Chesla DW; Chung MH
Am J Surg; 2016 Mar; 211(3):506-11. PubMed ID: 26754455
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
Singh P; Wig JD; Srinivasan R; Radotra BD
Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
[TBL] [Abstract][Full Text] [Related]
28. A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Int J Cancer; 2021 Jan; 148(1):238-251. PubMed ID: 32745259
[TBL] [Abstract][Full Text] [Related]
29. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
30. Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease.
Popp FC; Popp MC; Zhao Y; Betzler C; Kropf S; Garlipp B; Benckert C; Kalinski T; Lippert H; Bruns CJ
BMC Cancer; 2017 Mar; 17(1):229. PubMed ID: 28356064
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
32. High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma.
Xie H; Jiang W; Xiao SY; Liu X
J Histochem Cytochem; 2013 Feb; 61(2):148-55. PubMed ID: 23124118
[TBL] [Abstract][Full Text] [Related]
33. SMAD4 expression predicts local spread and treatment failure in resected pancreatic cancer.
Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2015 May; 44(4):660-4. PubMed ID: 25760429
[TBL] [Abstract][Full Text] [Related]
34. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
[TBL] [Abstract][Full Text] [Related]
35. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Davis-Yadley AH; Abbott AM; Pimiento JM; Chen DT; Malafa MP
Pancreas; 2016 Aug; 45(7):974-9. PubMed ID: 26692443
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients.
Paiella S; Malleo G; Cataldo I; Gasparini C; De Pastena M; De Marchi G; Marchegiani G; Rusev B; Scarpa A; Girelli R; Giardino A; Frigerio I; D'Onofrio M; Secchettin E; Bassi C; Salvia R
Langenbecks Arch Surg; 2018 Mar; 403(2):213-220. PubMed ID: 28983662
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis.
Wang JD; Jin K; Chen XY; Lv JQ; Ji KW
Oncotarget; 2017 Mar; 8(10):16704-16711. PubMed ID: 28053288
[TBL] [Abstract][Full Text] [Related]
40. Multiomics integrative analysis for gene signatures and prognostic values of m
Gao W; Cheng L; He S; Li W; Zhou C; Zhou B; Liu J; Xu J; Yu X; Zhu H
Aging (Albany NY); 2020 Oct; 12(20):20587-20610. PubMed ID: 33082301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
